(Q36823811)

16 August 2017

1 reference

title

Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis (English)

1 reference

16 August 2017

1 reference

1

Paul Emery

0 references

Cem Gabay

series ordinal

2

object named as

Cem Gabay

1 reference

16 August 2017

Maarten Kraan

3

1 reference

16 August 2017

Juan Gomez-Reino

series ordinal

4

1 reference

16 August 2017

publication date

16 May 2007

1 reference

Rheumatology International

16 August 2017

published in

1 reference

16 August 2017

volume

27

1 reference

16 August 2017

issue

9

1 reference

16 August 2017

page(s)

793-806

1 reference

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-007-0357-Y

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

How to predict prognosis in early rheumatoid arthritis

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis

1 reference

12 December 2020

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).

1 reference

12 December 2020

The links between joint damage and disability in rheumatoid arthritis

1 reference

12 December 2020

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

12 December 2020

Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

12 December 2020

Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis

1 reference

12 December 2020

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease

1 reference

12 December 2020

Asymptomatic synovitis precedes clinically manifest arthritis

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

1 reference

12 December 2020

Laboratory testing in autoimmune rheumatic diseases

1 reference

12 December 2020

A reappraisal of HAQ disability in rheumatoid arthritis

1 reference

12 December 2020

C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept

1 reference

12 December 2020

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

12 December 2020

Biochemical markers of joint tissue turnover in early rheumatoid arthritis

1 reference

12 December 2020

Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care

1 reference

12 December 2020

Joint erosions and patients with early rheumatoid arthritis

1 reference

12 December 2020

Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis

1 reference

12 December 2020

Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis

1 reference

12 December 2020

Relationship between histological findings and clinical findings in rheumatoid arthritis

1 reference

12 December 2020

Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis

1 reference

12 December 2020

Infliximab treatment reduces complement activation in patients with rheumatoid arthritis

1 reference

12 December 2020

Work disability in early rheumatoid arthritis

1 reference

12 December 2020

Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants

1 reference

12 December 2020

Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system

1 reference

12 December 2020

How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies.

1 reference

12 December 2020

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis

1 reference

12 December 2020

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

12 December 2020

Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

1 reference

12 December 2020

Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.

1 reference

12 December 2020

Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate

1 reference

12 December 2020

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

1 reference

12 December 2020

The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

1 reference

12 December 2020

Predictors of radiographic joint damage in patients with early rheumatoid arthritis

1 reference

12 December 2020

Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease

1 reference

12 December 2020

Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability

1 reference

12 December 2020

Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis

1 reference

12 December 2020

Selecting criteria for monitoring patients with rheumatoid arthritis

1 reference

12 December 2020

The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis

1 reference

12 December 2020

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

1 reference

12 December 2020

Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care.

1 reference

12 December 2020

The pathogenesis of rheumatoid arthritis: a guide to therapy

1 reference

12 December 2020

High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.

1 reference

12 December 2020

Infliximab treatment maintains employability in patients with early rheumatoid arthritis

1 reference

12 December 2020

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

1 reference

12 December 2020

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial

1 reference

12 December 2020

Differentiating the efficacy of the tumor necrosis factor inhibitors

1 reference

12 December 2020

Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study

1 reference

12 December 2020

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

1 reference

12 December 2020

Predictors of functional status in patients with early rheumatoid arthritis

1 reference

12 December 2020

Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

1 reference

12 December 2020

CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes

1 reference

12 December 2020

Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function

1 reference

12 December 2020

Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein

1 reference

12 December 2020

Immune-mediated inflammatory disorders (I.M.I.D.s): the economic and clinical costs

1 reference

12 December 2020

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

10.1007/S00296-007-0357-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1006215879

0 references

1 reference